Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: A phase IIb trial

Stefan Zeuzem, Thomas Berg, Edward Gane, Peter Ferenci, Graham R. Foster, Michael W. Fried, Christophe Hezode, Gideon M. Hirschfield, Ira Jacobson, Igor Nikitin, Paul J. Pockros, Fred Poordad, Jane Scott, Oliver Lenz, Monika Peeters, Vanitha Sekar, Goedele De Smedt, Rekha Sinha, Maria Beumont-Mauviel

Research output: Contribution to journalArticlepeer-review

199 Scopus citations

Fingerprint

Dive into the research topics of 'Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: A phase IIb trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science